Skip to main content
The Journal of Infectious Diseases logoLink to The Journal of Infectious Diseases
. 2011 Feb 1;203(3):430–435. doi: 10.1093/infdis/jiq062

Human Natural Killer Cells Exhibit Direct Activity Against Aspergillus fumigatus Hyphae, But Not Against Resting Conidia

Stanislaw Schmidt 1, Lars Tramsen 1, Mitra Hanisch 1, Jean-Paul Latgé 2, Sabine Huenecke 1, Ulrike Koehl 1, Thomas Lehrnbecher 1,
PMCID: PMC3071101  PMID: 21208932

Abstract

Because natural killer (NK) cells kill tumor cells and combat infections, there is growing interest in adoptively transferring NK cells to hematopoietic stem cell recipients. Unfortunately, in humans, the activity of NK cells against Aspergillus species, the major cause of invasive fungal infection in stem cell recipients, are poorly characterized. Our results show that unstimulated and interleukin-2 prestimulated human NK cells kill Aspergillus fumigatus hyphae but do not affect resting conidia. Killing is also induced by the supernatant of prestimulated NK cells and human perforin. The high levels of interferon-γ and granulocyte macrophage colony-stimulating factor produced by prestimulated NK cells are significantly reduced by Aspergillus, indicating an immunosuppressive effect of the fungus. Whereas Aspergillus hyphae activate NK cells, resting, and germinating, conidia and conidia of ΔrodA mutants lacking the hydrophobic surface layer do not. Our results suggest that adoptively transferred human NK cells may be a potential antifungal tool in the transplantation context.


Despite improved chemotherapeutic regimens, relapse and infectious complications remain major causes of morbidity and mortality in the context of allogeneic hematopoietic stem cell transplantation [1, 2]. To improve outcome in transplant recipients, there is growing interest in adoptive immunotherapeutic strategies, such as the administration of antigen-specific T cells and natural killer (NK) cells. Whereas the administration of T cells is associated with the risk of potentially lethal graft-versus-host disease, NK cells are usually well tolerated and may even mitigate graft-versus-host disease [3]. In vitro data demonstrate that human NK cells are cytotoxic against a variety of tumor types, including acute lymphoblastic and myelogenous leukemia [4]. The potential clinical benefit of adoptive NK cell therapy is supported by the observation that patients with high-risk acutr myelogenous leukemia who received a transplant from an NK-cell alloreactive donor had a significantly lower relapse rate and a better event-free survival than did patients who received a transplant from a non–NK-alloreactive donor [5]. In addition to the killing of tumor cells, NK cells play a crucial role in combating infections due to a variety of pathogens [6]. To date, NK cells have been examined in a neutropenic mouse model. It was demonstrated that, in mice with pulmonary aspergillosis, the chemokine-mediated recruitment of NK cells is an important antifungal host defense mechanism, and the transfer of activated NK cells results in greater pathogen clearance [7, 8]. Unfortunately, in humans, the activity and antifungal mechanisms of NK cells against Aspergillus species are poorly characterized, although Aspergillus is the major cause of invasive fungal infection in allogeneic stem cell recipients, with a mortality up to 80% [9]. We therefore investigated the effect of human NK cells on various Aspergillus morphotypes, and our results suggest that adoptively transferred human NK cells may be a potential antifungal tool in hematopoietic transplant recipients at high risk of or experiencing invasive aspergillosis.

MATERIALS AND METHODS

Isolation and Cultivation of Primary Human NK Cells

Primary human NK cells were isolated from peripheral blood according to a protocol previously described with some modifications [10]. In brief, blood was obtained from healthy volunteers who had no evidence of previous invasive fungal infection. Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll/Paque density gradient, harvested, and washed twice. NK cells were isolated using a 2-step method; a negative selection using anti-CD3 MicroBeads was followed by a positive selection of CD56+CD3- cells using anti-CD56 antibodies (MACS magnetic column separation system; Miltenyi Biotech). The purity and viability of the isolated human CD56+CD3- NK cells were ≥95% and ≥98%, respectively, as determined by flow cytometry (FC-500, Beckmann Coulter) using the following antibodies: anti-CD3, CD14, CD45, and CD56, labeled with FITC, PE, ECD, and PC7, respectively, and 7-amino-actinomycin D for testing viability (all Beckmann Coulter). Anti-CD69 labeled with ECD was used for assessment of NK cell activation (Beckman Coulter). After isolation, NK cells were resuspended in X-VIVO 10 medium (Lonza) supplemented with 5% human frozen plasma (German Red Cross Blood Donor Service Baden-Wuerttemberg – Hessen). The NK cells were used immediately or further cultivated for 7–10 days in the presence of E.scherichia coli–derived recombinant human interleukin (IL)–2 (1000 U/mL added every third day; Novartis). The protocol was approved by the local ethics committee.

Preparation of A. fumigatus

The A. fumigatus strain AF4215 (MYA 1163; American Type Culture Collection) was grown on Sabouraud glucose agar (BD) at 37°C for 2–3 days. Conidia were harvested by gently scraping the surface of the slants with a sterile cotton stick, which was then washed in Hanks’ balanced saline solution (Gibco). The suspension was filtered through sterile gauze, and the number of the conidia was estimated in a Neubauer slide (LO–Laboroptik). Resting conidia were immediately used or stored at −20°C. For the preparation of germinating conidia, resting conidia were incubated for 6 h at 37°C in X-VIVO 10 medium [11]. For the preparation of A. fumigatus hyphae, conidia (7.5 × 104 per mL) were plated in flat-bottom cell culture plates (Nunc) and incubated in Yeast Nitrogen Base (Sigma-Aldrich) medium at 37°C for 17 h to allow formation of mycelium. Conidia of the ΔrodA mutant strain lacking the hydrophobic surface layer were grown on Sabouraud glucose agar plates at 25°C for 1 week and prepared as described above [12].

Assessment of Antifungal Activity

Activity against Aspergillus hyphae was assessed by means of the colorimetric assay with (2,3-bis[2-methoxy-4-nitro-5sulphenyl]2H-tetrazolium-5-carboxyanilide)sodium salt (XTT; Sigma-Aldrich) plus coenzyme Qo (2,3-dimethoxy-5methyl-1,4-benzoquinone; Sigma-Aldrich) using A. fumigatus as described previously with some modifications [13]. In brief, NK cells were added to A. fumigatus hyphae in different effector-to-target ratios and incubated for up to 6 h. Then, wells were washed twice with sterile water to lyse NK cells, and XTT wasdissolved in phosphate-buffered saline at a concentration of 0.25 mg/mL and 40 μg/mL coenzyme Qo were added. After incubation for 1 h at 37 C with 5% carbon dioxide, 100 μL were transferred to a 96-well plate, and the change in color (absorbance) was assessed spectrophotometrically at 450 nm with use of a 690-nm reference. Antihyphal activity was calculated according to the formula: percent hyphal damage = (1-X/C) × 100, where X is the absorbance of experimental wells and C is the absorbance of control wells with hyphae only. For some experiments, a polycarbonate cell culture insert (Greiner Bio-One; pore size, 0.4 μm) was used to separate A. fumigatus hyphae and NK cells.

In addition to the XTT test, viability staining with 5-carboxyfluorescein diacetate/propidfium iodide was performed (FungaLight; Molecular Probes).

For the evaluation of the activity of NK cells against Aspergillus conidia, resting conidia were incubated with or without NK cells for 24 h. A total of 100 μL of the suspension was spread onto Sabouraud glucose agar plates and incubated at 37°C for 24 h. After 24 h, the conidial damage was assessed by determination of colony-forming units (CFUs) per mL. The comparison of the number of CFUs with and the number of CFUs without co-incubated NK cells indicated the antifungal activity of NK cells against resting conidia of A. fumigatus.

Measurement of Perforin, Interferon (IFN) -γ, Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF) and RANTES (CCL5)

The concentration of perforin, IFN-γ, GM-CSF, and RANTES in the supernatant was measured using commercially available enzyme-linked immunoabsorbent assays (ELISAs). According to the manufacturers’ instruction, the detection limit for perforin was 40 pg/mL (Diaclone); for IFN-γ, 4 pg/mL (eBiosciences); for GM-CSF, 7.8 pg/mL; and for RANTES, 31.2 pg/mL (GM-CSF and RANTES: R&D Systems).

Evaluation of the Effect of Perforin

To block perforin-mediated cytotoxicity of the NK cells, NK cells were treated with 10 nM concanamycin A for 2 h (Sigma Aldrich) [14]. NK cells were washed 3 times in X-VIVO 10 medium, assessed for viability by flow-cytometry, and placed for the experiment.

Human perforin isolated from cytotoxic granules of YT cells (Alexis Biochemicals) was used at a concentration of 100 ng/mL.

Statistical Analysis

Data were analyzed using GraphPad Prism (GraphPad Software). Comparisons between experimental groups were performed by unpaired Student’s t test. Pearson’s correlation was used to analyze the degree of linear relationship between 2 variables. A 2-sided P value <.05 was considered to be statistically significant.

RESULTS

Activation of Primary Human NK Cells by A. fumigatus

To evaluate whether different morphotypes of A. fumigatus are able to activate human NK cells, we assessed the up-regulation of CD69 on unstimulated human NK cells when co-incubated with A. fumigatus hyphae, resting conidia, and germinating conidia, respectively. Whereas CD69 on NK cells is up-regulated by A. fumigatus hyphae indicating activation, wild-type resting conidia and germinating conidia do not affect CD69 up-regulation of unstimulated NK cells (Figure 1). Similarly, conidia of ΔrodA mutants lacking the hydrophobic surface layer are not able to activate NK cells (Figure 1). In addition, the activation of NK cells by A. fumigatus hyphae is prevented by a membrane with a pore size of 0.4 μm, which separates human NK cells and the fungus, suggesting that close vicinity or direct NK cell–fungus interaction is responsible for CD69 up-regulation (data not shown).

Figure 1.

Figure 1.

Aspergillus hyphae, but not resting and germinating Aspergillus conidia, up-regulate CD69 expression on human CD56+CD3- natural killer (NK) cells. A, Overlaying histograms represent unstimulated NK cells (gray curve) and NK cells co-incubated with different Aspergillus morphotypes or interleukin (IL) 2 for 24 h (black solid line). A representative histogram from 5 experiments is shown. B. Percentage of activated CD56+CD3- NK cells. The horizontal bar represents the median. a, Co-incubation with heat-killed wild-type (wt) resting Aspergillus conidia; b, co-incubation with heat-killed wt germinating Aspergillus conidia; c, co-incubation with wt Aspergillus hyphae; d, co-incubation with resting conidia of the ΔrodA mutant lacking the hydrophobic surface layer; and e, stimulation with IL-2. Data were obtained by at least 5 separate experiments.

Unstimulated and IL-2–Stimulated Primary Human NK Cells Kill A. fumigatus Hyphae, But Do Not Affect Resting A. fumigatus Conidia

Our results demonstrate that both unstimulated and IL-2 prestimulated human NK cells kill A. fumigatus hyphae, as revealed by means of the XTT assay (Figure 2) and viability staining with 5-carboxyfluorescein diacetate /propidium iodide (Figure S1). The extent of hyphal killing of IL-2 prestimulated NK cells is significantly higher, compared with unstimulated NK cells (P = .026). In addition, increasing effector-to-target ratios result in higher hyphal damage. For example, when coincubating NK cells and Aspergillus hyphae for 6 h at effector-to-target ratios of 10:1, 20:1, and 50:1, the mean hyphal killing of unstimulated NK cells ranges from 10% (standard deviation [SD], 4%) to 24% (SD, 4%) and 34% (SD, 13%), respectively (each test performed at least 3 times). Similarly, for IL-2 prestimulated NK cells, hyphal killing ranges from 15% (SD, 7%) to 24% (SD, 6%) and 43% (SD, 7%), respectively (each test performed at least 3 times). In contrast to A. fumigatus hyphae, resting conidia are not affected by NK cells, whether unstimulated or prestimulated with IL-2 (Figure 2).

Figure 2.

Figure 2.

Unstimulated (white columns) and interleukin (IL)-2 prestimulated (black columns) natural killer (NK) cells exhibit killing activity against Aspergillus fumigatus hyphae (left side), but not against resting conidia (right side). NK cells were co-incubated at an effector:target ratio of 20:1 with Aspergillus hyphae (6 h) or with Aspergillus conidia (24 h), respectively. The antifungal activity of NK cells is presented as the percentage of damaged hyphae or the reduction of the number of colony forming units of resting conidia, respectively (see Materials and Methods). Columns represent mean and standard deviation of at least three separate experiments. *P= .026.

The Perforin-Pathway is Involved in Aspergillus Hyphal Killing by NK Cells

The levels of perforin, which is constitutively expressed by NK cells, are significantly higher in the supernatant of IL-2 prestimulated than in unstimulated NK cells (median, 18,434 pg/mL [range, 13,185–43,113 pg/mL]; and 3808 pg/mL [range, 2271–5208 pg/mL], respectively; P = .013; n = 5 each). Higher perforin levels correlate with higher killing activity of Aspergillus hyphae by both unstimulated (r = 0.94; P < .0002; data from 9 tests, each performed in triplicates) and IL-2 prestimulated human NK cells (r = 0.96; P < .0001; data from 9 tests, each performed in triplicates). When separating IL-2 prestimulated human NK cells and A. fumigatus hyphae by a membrane (pore size, 0.4 μm), a similar extent of hyphal damage is seen, compared with the context without membrane, indicating that hyphal damage does not depend on direct NK cell–fungal interaction (Figure 3A). This is further supported by the fact that killing of A. fumigatus hyphae is induced by the supernatant of IL-2 prestimulated NK cells (Figure 3A) and by purified human perforin (Figure 3B). Blocking of perforin-mediated cytotoxicity via concanamycin A results in a significant decrease of anti-Aspergillus activity of IL-2 prestimulated NK cells (Figure 3B), indicating that perforin plays an important role in the antifungal activity of NK cells.

Figure 3.

Figure 3.

Natural killer (NK) cells damage Aspergillus hyphae by soluble molecules. A, A similar extent of hyphal damage is seen when co-incubating IL-2 prestimulated NK cells with Aspergillus hyphae in the presence (black column) or absence (white column) of a membrane (pore size, 0.4 μm) separating NK cells and Aspergillus. Comparable results were seen when Aspergillus hyphae were co-incubated with the supernatant of IL-2 prestimulated NK cells (gray column). B, Addition of 10 nM concanamycin A (black column) results in a significant decrease of killing activity of of IL-2 prestimulated NK cells against Aspergillus fumigatus hyphae (white column; *P = .01). Isolated human perforin alone exhibits a significant killing of Aspergillus fumigatus hyphae (gray column). Columns represent mean and standard deviation of at least 3 separate experiments in all figures.

Influence of A. fumigatus Morphotypes on IFN-γ, GM-CSF, and RANTES Production by Human NK Cells

Because IFN-γ and GM-CSF play an important role in the host response to invasive aspergillosis, we assessed the influence of different morphotypes of A. fumigatus on the production of these molecules by human NK cells. Without adding A. fumigatus hyphae, higher levels of IFN-γ are measured in the supernatant of IL-2 prestimulated, compared with unstimulated NK cells (data not shown). Whereas coincubation with A. fumigatus hyphae does not significantly influence the level of IFN-γ in the supernatant of unstimulated NK cells, the concentration of IFN-γ in the supernatant of IL-2 prestimulated NK cells is significantly reduced by the addition of A. fumigatus hyphae (P = .013) and of germinating conidia (P = .016) (Figure 4A). Similarly, the levels of GM-CSF are reduced in the supernatant of IL-2 prestimulated NK co-incubated with A. fumigatus hyphae (P = .037) and of germinating conidia (P = .016) (Figure 4B). In contrast, resting conidia of A. fumigatus do not affect the levels of both IFN-γ and GM-CSF (Figure 4A and 4B). The production of RANTES, which plays a major role in inflammatory processes and is highly produced by IL-2 prestimulated NK cells, is not altered by any of the A. fumigatus morphotypes (Figure 4C).

Figure 4.

Figure 4.

Aspergillus hyphae and germinating conidia decrease interferon (IFN)–γ and granulocyte macrophage colony-stimulating factor (GM-CSF) levels in the supernatant of IL-2 prestimulated natural killer (NK) cells, but do not affect the concentration of RANTES. Co-incubation with Aspergillus fumigatus hyphae (light gray columns) or A. fumigatus germinating conidia (black columns) leads to a significant reduction of IFN-γ and GM-CSF production (Figure 4A: *P = .013; **P = .016, and Figure 4B: *P = .037; **P = .016), whereas the production of RANTES remains unaffected (Figure 4C). Co-incubation with A. fumigatus resting conidia (dark gray columns) has no significant effect on the production of IFN-γ, GM-CSF, and RANTES. Columns represent mean and standard deviation of at least 3 separate experiments in all figures.

DISCUSSION

Here, we report for the first time to our knowledge that both unstimulated and IL-2 prestimulated human NK cells kill A. fumigatus hyphae but are not active against resting A. fumigatus conidia. These results might have an important impact on the strategy of adoptive NK cell immunotherapy in hematopoietic transplant recipients. Whereas the cytotoxic effect of NK cells against malignant cells is well described and is already being evaluated in clinical trials, there are only few data on the effect of human NK cells against fungi, in particular against A. fumigatus, the most important fungal pathogen in transplantation. Our results show that IL-2 prestimulated NK cells have a higher antifungal activity in vitro against A. fumigatus than unstimulated NK cells, which corroborates previous studies investigating the activity of human NK cells against various malignancies [1517]. Of note, IL-2 was used in these clinical trials either for prestimulation of NK cells ex vivo or as NK cell activation in vivo. In contrast to the killing of Aspergillus hyphae, we did not observe that unstimulated or IL-2 prestimulated human NK cells damaged resting A. fumigatus conidia. In addition, neither resting nor germinating conidia had an effect in activating unstimulated NK cells. This is in line with a recent report that dendritic cells and alveolar macrophages are not activated by resting Aspergillus conidia resulting from the surface hydrophobic layer on the fungus [12]. When removing the hydrophobic layer chemically or genetically (ΔrodA mutant), the altered conidial morphotype was able to activate dendritic cells and alveolar macrophages. In contrast, our results show that the ΔrodA mutant did not induce NK cell activation, indicating that different mechanisms are responsible for the activation of dendritic cells, alveolar macrophages, and NK cells by Aspergillus, which is the focus of our current research.

We further evaluated potential mechanisms by which NK cells kill A. fumigatus hyphae. Because perforin is known as a key mediator of NK cell-mediated cytotoxicity against malignant cells and a variety of microbes, we focused on this molecule. Corroborating previous reports on NK cell activity against Cryptococcus neoformans, our data indicate that NK cells constitutively express activity against A. fumigatus [14]. In addition, similar to NK cell antitumor and anticryptococcal activity, the activity against Aspergillus can be up-regulated by pre-activation of NK cells with IL-2 [15, 18]. Because perforin production is up-regulated in IL-2 prestimulated NK cells, purified human perforin exhibits killing of A. fumigatus hyphae, and blocking of perforin-mediated cytotoxicity via concanamycin A results in a significant decrease of anti-Aspergillus activity, our data suggest that perforin plays a significant role in the killing of Aspergillus. Of note, NK cell–mediated killing of Cryptococcus requires contact of NK cells with the fungus, whereas the damage of Aspergillus does not depend on direct NK cell–fungal interaction. Further studies have to evaluate whether other molecules released by NK cells are also involved in anti-Aspergillus activity.

In addition to the direct cytotoxic activity of NK cells, which is mediated at least in part by perforin, the secretion of soluble factors such as IFN-γ, GM-CSF, and RANTES up-regulates the activity of phagocytes and has an important impact on the cellular immune response [19, 20]. For example, NK cells potentiate, via secreted IFN-γ, the fungicidal activity of macrophages, which leads to a higher killing of C. neoformans [21]. In addition, the transfer of activated NK cells from wild-type, but not from IFN-γ-deficient mice, results in greater pathogen clearance in mice with pulmonary aspergillosis [8]. However, we observed that the IFN-γ release of IL-2 prestimulated NK cells is down-regulated by A. fumigatus hyphae and germinating conidia, but not by resting conidia, indicating an immunosuppressive effect depending on the morphotype of the fungus. A similar effect was previously reported in mice, in which Candida albicans inhibited the IFN-γ secretion by NK cells [22]. Whereas the production of GM-CSF is also reduced by Aspergillus hyphae and by germinating conidia, the production of RANTES is not affected, indicating specific immunosuppressive effects of the fungus. Of note, the viability of the NK cells was not significantly affected when co-incubated with A.fumigatus hyphae or germinating conidia (data not shown). Because Aspergillus mycotoxins, such as gliotoxin or citrinin, are known to affect IFN-γ production by T cells, one is prompted to speculate that these toxins are also responsible for the down-regulation of IFN-γ or GM-CSF secretion by human NK cells, which might have important clinical implications [23]. On the other hand, no significant improvement of outcome has been demonstrated by the intravenous administration of IFN-γ to patients with invasive aspergillosis, indicating that the IFN-γ effect is complex and might depend on the microenvironment and timing [24].

Taken together, our data demonstrate that human NK cells exhibit direct and, via IFN-γ, also indirect killing activity against A. fumigatus hyphae. Therefore, in the context of transplantation, adoptive immunotherapy involving NK cells may be a potential tool in the antifungal armamentarium, administered either alone or in combination with other antifungal therapies. However, prophylactic strategies using NK cells might be limited because of the lack of activity against infecting conidia. Before evaluating the antifungal activity of NK cells in the clinical setting, future studies have to address several questions, including the exact mechanisms of NK cell activation by the fungus and how Aspergillus suppresses the activity of NK cells.

Funding

This work was supported by research funding from the Madeleine Schickedanz KinderKrebsStiftung to TL.

References

  • 1.Dickinson AM, Harrold JL, Cullup H. Haematopoietic stem cell transplantation: can our genes predict clinical outcome? Expert Rev Mol Med. 2007;9:1–19. doi: 10.1017/S1462399407000488. [DOI] [PubMed] [Google Scholar]
  • 2.Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) database. Clin Infect Dis. 2010;50:1091–100. doi: 10.1086/651263. [DOI] [PubMed] [Google Scholar]
  • 3.Passweg JR, Koehl U, Uharek L, Meyer-Monard S, Tichelli A. Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation. Best Pract Res Clin Haematol. 2006;19:811–24. doi: 10.1016/j.beha.2006.06.004. [DOI] [PubMed] [Google Scholar]
  • 4.Gill S, Olson JA, Negrin RS. Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses. Biol Blood Marrow Transplant. 2009;15:765–76. doi: 10.1016/j.bbmt.2009.01.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ruggeri L, Mancusi A, Capanni M, et al. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood. 2007;110:433–40. doi: 10.1182/blood-2006-07-038687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Newman KC, Riley EM. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat Rev Immunol. 2007;7:279–91. doi: 10.1038/nri2057. [DOI] [PubMed] [Google Scholar]
  • 7.Morrison BE, Park SJ, Mooney JM, Mehrad B. Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J Clin Invest. 2003;112:1862–70. doi: 10.1172/JCI18125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Park SJ, Hughes MA, Burdick M, Strieter RM, Mehrad B. Early NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis. J Immunol. 2009;182:4306–12. doi: 10.4049/jimmunol.0803462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Pagano L, Caira M, Nosari A, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study–Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis. 2007;45:1161–70. doi: 10.1086/522189. [DOI] [PubMed] [Google Scholar]
  • 10.Brill KJ, Li Q, Larkin R, et al. Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms. Infect Immun. 2001;69:1755–65. doi: 10.1128/IAI.69.3.1755-1765.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Serbina NV, Cherny M, Shi C, et al. Distinct responses of human monocyte subsets to Aspergillus fumigatus conidia. J Immunol. 2009;183:2678–87. doi: 10.4049/jimmunol.0803398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Aimanianda V, Bayry J, Bozza S, et al. Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature. 2009;460:1117–21. doi: 10.1038/nature08264. [DOI] [PubMed] [Google Scholar]
  • 13.Beck O, Topp MS, Koehl U, et al. Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus. Blood. 2006;107:2562–9. doi: 10.1182/blood-2005-04-1660. [DOI] [PubMed] [Google Scholar]
  • 14.Ma LL, Wang CL, Neely GG, Epelman S, Krensky AM, Mody CH. NK cells use perforin rather than granulysin for anticryptococcal activity. J Immunol. 2004;173:3357–65. doi: 10.4049/jimmunol.173.5.3357. [DOI] [PubMed] [Google Scholar]
  • 15.Huenecke S, Zimmerman SY, Kloess S, et al. IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusion. J Immunother. 2010;33:200–210. doi: 10.1097/CJI.0b013e3181bb46f7. [DOI] [PubMed] [Google Scholar]
  • 16.Rubnitz JE, Inaba H, Ribeiro RC, et al. NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia. J Clin Oncol. 2010;28:955–9. doi: 10.1200/JCO.2009.24.4590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Miller JS, Soignier Y, Panoskaltsis-Mortari A, et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood. 2005;105:3051–7. doi: 10.1182/blood-2004-07-2974. [DOI] [PubMed] [Google Scholar]
  • 18.Marr KJ, Jones GJ, Zheng C, et al. Cryptococcus neoformans directly stimulates perforin production and rearms NK cells for enhanced anticryptococcal microbicidal activity. Infect Immun. 2009;77:2436–46. doi: 10.1128/IAI.01232-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Gil-Lamaignere C, Simitsopoulou M, Roilides E, Maloukou A, Winn RM, Walsh TJ. Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes. J Infect Dis. 2005;191:1180–7. doi: 10.1086/428503. [DOI] [PubMed] [Google Scholar]
  • 20.Uicker WC, Doyle HA, McCracken JP, Langlois M, Buchanan KL. Cytokine and chemokine expression in the central nervous system associated with protective cell-mediated immunity against Cryptococcus neoformans. Med Mycol. 2005;43:27–38. doi: 10.1080/13693780410001731510. [DOI] [PubMed] [Google Scholar]
  • 21.Kawakami K, Koguchi Y, Qureshi MH, et al. NK cells eliminate Cryptococcus neoformans by potentiating the fungicidal activity of macrophages rather than by directly killing them upon stimulation with IL-12 and IL-18. Microbiol Immunol. 2000;44:1043–50. doi: 10.1111/j.1348-0421.2000.tb02601.x. [DOI] [PubMed] [Google Scholar]
  • 22.Murciano C, Villamon E, O'Connor JE, Gozalbo D, Gil ML. Killed Candida albicans yeasts and hyphae inhibit gamma interferon release by murine natural killer cells. Infect Immun. 2006;74:1403–6. doi: 10.1128/IAI.74.2.1403-1406.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Wichmann G, Herbarth O, Lehmann I. The mycotoxins citrinin, gliotoxin, and patulin affect interferon-gamma rather than interleukin-4 production in human blood cells. Environ Toxicol. 2002;17:211–8. doi: 10.1002/tox.10050. [DOI] [PubMed] [Google Scholar]
  • 24.Safdar A, Rodriguez GH, Lichtiger B, et al. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions. Cancer. 2006;106:2664–71. doi: 10.1002/cncr.21929. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Infectious Diseases are provided here courtesy of Oxford University Press

RESOURCES